American Healthcare REIT officer to sell 2,000 shares

American Healthcare REIT, Inc. (AHR) received a Rule 144 notice from officer Mark Foster for a planned sale of 2,000 shares of common stock.

Rhea-AI Filing Summary

American Healthcare REIT, Inc. (AHR) received a Rule 144 notice from officer Mark Foster for a planned sale of 2,000 shares of common stock. The shares relate to restricted stock vesting on 02/09/2025, with a planned sale date of 09/01/2026 through Merrill on the NYSE. The notice also reports that Foster sold 2,500 shares of common stock on 06/24/2026 for an aggregate price of $121,450. The filing states that 217,998,775 shares of American Healthcare REIT common stock are outstanding.

Key Figures

Shares to be sold: 2,000 shares of common stock Aggregate market value of planned sale: $110,780 Shares outstanding: 217,998,775 shares +4 more

7 metrics

Shares to be sold 2,000 shares of common stock Planned Rule 144 sale by Mark Foster, approximate sale date 09/01/2026

Aggregate market value of planned sale $110,780 Aggregate market value for 2,000 shares in the Rule 144 notice

Shares outstanding 217,998,775 shares Common stock of American Healthcare REIT, Inc. stated as outstanding

Shares sold in past 3 months 2,500 shares of common stock Shares sold by Mark Foster on 06/24/2026

Aggregate sale price for prior sale $121,450 Aggregate price for 2,500 shares sold on 06/24/2026

Restricted stock vesting date 02/09/2025 Vesting date associated with the securities to be sold

Approximate sale date 09/01/2026 Approximate date of proposed sale under Rule 144

Key Terms

Rule 144, restricted stock vesting, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 02/09/2025 | Restricted Stock Vesting | American Healthcare REIT Inc"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"Common | Merrill ... | 2000 | 110780 | 217998775 | 09/01/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by AHR officer Mark Foster disclose?

It discloses that Mark Foster plans to sell 2,000 shares of American Healthcare REIT, Inc. common stock under Rule 144, tied to restricted stock vesting on 02/09/2025, with an anticipated sale date of 09/01/2026 through Merrill on the NYSE.

How many AHR shares does Mark Foster plan to sell in this Form 144?

Mark Foster plans to sell 2,000 shares of American Healthcare REIT, Inc. common stock, with an indicated aggregate market value of $110,780 as stated in the Form 144 securities information section.

What prior AHR stock sales by Mark Foster are reported in this Form 144?

The filing reports that Mark Foster sold 2,500 shares of American Healthcare REIT, Inc. common stock on 06/24/2026 for an aggregate sale price of $121,450 during the three months preceding the notice.

How many American Healthcare REIT (AHR) shares are outstanding according to this filing?

The Form 144 states that there are 217,998,775 shares of American Healthcare REIT, Inc. common stock outstanding, a baseline figure used in the Rule 144 disclosure and not the amount being sold.

What is the relationship between the AHR shares being sold and restricted stock vesting?

The securities to be sold are identified as relating to restricted stock vesting on 02/09/2025. The Form 144 links the 2,000 shares planned for sale to this restricted stock vesting event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:38 PM EDT Accepted by SEC EDGAR 09/01/2026 - 04:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001941750
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMERICAN HEALTHCARE REIT, INC.
SEC File Number	001-41951
Address of Issuer	18191 Von Karman Avenue, Suite 300 Irvine CALIFORNIA 92612
Phone	949-270-9200
Name of Person for Whose Account the Securities are To Be Sold	Mark Foster
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Drive, 5th Floor Columbus OH 43240	2000	110780	217998775	09/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/09/2025	Restricted Stock Vesting	American Healthcare REIT Inc			2000	02/09/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Foster 18191 Von Karman Avenue, Suite 300 Irvine CA 92612	Common	06/24/2026	2500	121450

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Mark Foster
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)